IFIH1 and interstitial lung disease: Recently, a FLAIR model was developed that combined five clinical indices, which included ferritin, lactate dehydrogenase, MDA5 antibody, HRCT Imagine semi-quantitative score, and rapidly-progressive ILD, to predict amyopathic dermatomyositis survival time (30).